Locally Secreted Semaphorin 4D Is Engaged in Both Pathogenic Bone Resorption and Retarded Bone Regeneration in a Ligature-Induced Mouse Model of Periodontitis

• Published in: International journal of molecular sciences Vol. 23; no. 10; p. 5630
• Main Authors: Ishii, Takenobu, Ruiz-Torruella, Montserrat, Yamamoto, Kenta, Yamaguchi, Tsuguno, Heidari, Alireza, Pierrelus, Roodelyne, Leon, Elizabeth, Shindo, Satoru, Rawas-Qalaji, Mohamad, Pastore, Maria Rita, Ikeda, Atsushi, Nakamura, Shin, Mawardi, Hani, Kandalam, Umadevi, Hardigan, Patrick, Witek, Lukasz, Coelho, Paulo G, Kawai, Toshihisa
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 18.05.2022; MDPI
• Subjects: Alveolar bone; Biomedical materials; Bone growth; bone regeneration; Bone remodeling; Bone resorption; CD72 antigen; Gene expression; Gum disease; Inflammation; Insulin-like growth factor I; osteoblasts; Osteoclastogenesis; Osteoclasts; Osteogenesis; Osteoporosis; Periodontitis; Proteins; Regeneration; Regeneration (physiology); Rheumatoid arthritis; Semaphorin 4D; TRANCE protein; Tumor necrosis factor-TNF; Tumor necrosis factor-α; bone regeneration; osteoblasts; Semaphorin 4D; osteoclasts; periodontitis
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23105630

It is well known that Semaphorin 4D (Sema4D) inhibits IGF-1-mediated osteogenesis by binding with PlexinB1 expressed on osteoblasts. However, its elevated level in the gingival crevice fluid of periodontitis patients and the broader scope of its activities in the context of potential upregulation of osteoclast-mediated periodontal bone-resorption suggest the need for further investigation of this multifaceted molecule. In short, the pathophysiological role of Sema4D in periodontitis requires further study. Accordingly, attachment of the ligature to the maxillary molar of mice for 7 days induced alveolar bone-resorption accompanied by locally elevated, soluble Sema4D (sSema4D), TNF-α and RANKL. Removal of the ligature induced spontaneous bone regeneration during the following 14 days, which was significantly promoted by anti-Sema4D-mAb administration. Anti-Sema4D-mAb was also suppressed in vitro osteoclastogenesis and pit formation by RANKL-stimulated BMMCs. While anti-Sema4D-mAb downmodulated the bone-resorption induced in mouse periodontitis, it neither affected local production of TNF-α and RANKL nor systemic skeletal bone remodeling. RANKL-induced osteoclastogenesis and resorptive activity were also suppressed by blocking of CD72, but not Plexin B2, suggesting that sSema4D released by osteoclasts promotes osteoclastogenesis via ligation to CD72 receptor. Overall, our data indicated that ssSema4D released by osteoclasts may play a dual function by decreasing bone formation, while upregulating bone-resorption.